In collaboration with the Institut Pasteur de Lille and other university researchers, ILiAD Biotechnologies is investigating the potential role of Bordetella pertussis colonizing infections in Alzheimer’s disease, multiple sclerosis, asthma, auto-immune and allergic diseases, as well as the potential for ILiAD drug candidates to prevent and treat these illnesses.
